Systematic review reveals economic burden of interstitial lung disease, indicating that better treatments and support can improve health outcomes.
Interstitial lung disease imposes a substantial economic impact. Early diagnosis, effective treatments targeting ILD and comorbidities, appropriate social support, and an optimized health delivery system may reduce the overall cost and improve health outcomes.
No takes yet. Share an insight, caveat, or question.
Chiew et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: